Case File
efta-02565756DOJ Data Set 11OtherEFTA02565756
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02565756
Pages
8
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S
Sent:
Monday, February 11, 2013 5:08 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Ens, Amanda; Weissend, Renee E
Subject:
NEW HY RMBS BWIC - 54.3mm of RFMSI 04-54 1M1 ® 85-16 (6.51% yield/2.97 durn)
Jeffrey
We should buy 51MM of this bond.
US Onshore Clients — Blue Sky (U.S. State Securities Law): Please confirm Blue Sky eligibility before soliciting to a US
Onshore client by entering the CUSIP into the web tool located at:
http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage.html and review to see if your client's state of residence is listed.
If you receive 'NO SECURITY FOUND', 'NO STATES FOUND' or the security DOES NOT HAVE A CUSIP or is not USD-
denominated, then please contact your SM or local compliance officer and provide the requested security and client
information. Please note that a suitability review and other pre-trade procedures must still be followed.
THE BOND:
The RFMSI 04-S4 1M1 is a Prime Seasoned Fix 5.25% Sub bond backed by 105 months seasoned fix mortgages. The
bond has 2.38% credit enhancement vs 7.08% 60+ delinquencies, for a 0.34x coverage ratio.
THE COLLATERAL:
The pool consists of 145 Prime loans that are 105 months seasoned with an average updated LTV of 56%. The average
balance of the loans is 5296k — this coupled with the low updated LTV should result in both low CDRs and Severities. In
fact, there has been only 2 CDR prints over the last 12 months and the average severity of those 2 prints is 20.64%. Our
base case assumes 35% severity ramping down to 30% over 3 years. What's more interesting is that the 5 foreclosure
loans in the pipe have an updated LTV of 41%, which is even lower than the overall pool LTV of 56%. According to our
model, this should translate to lower severities at liquidation.
THE STORY:
For investors looking for a housing recovery play backed by seasoned Prime collateral, this bond offers a great convexity
story levered to prepayments and overall homeowner performance.
Please call the desk with all bids/inquiries related to this bond. X32124
HIGHLIGHTS
HPI Updated LTV = 56%
87% of the borrowers have not missed a payment in the past 2 years
EFTA_R1_01730425
EFTA02565756
105 months seasoned
735 FICO
$296k average balance
**Source: Bloomberg
REMSI 2004-54 1M1 Offered @ 85-16
BOND DESCRIPTION
Prepay Rate
20 CPR
24 CPR
28 CPR
Cusip:
76111XHZ9
Default Rate
2 ramp 20 4 3 ramp 12 2 CDR
2 ramp 20 4 3 ramp 36 1.75 CDR
2 ramp 20 4 3 ramp 12 1.5 CDR
Original Face:
4,314,300
Default Severity
40 ramp 36 35
35 ramp 36 30
30
Current Face:
2
EFTA_R1_01730426
EFTA02565757
2,002,760
Delinq Rate
7.5 Percent
7.5 Percent
7.5 Percent
Bond Type:
Prime Fix 5.25% Men
Delinq Advance (% of P&I)
100
100
100
Ratings (S&P/Moodys/Fitch):
CCC/-/NR
Current Coupon:
5.250%
Yield @ Base Case
6.509%
Price @ 85.16
WAL @ Base Case
4.03
Yield
2.124
3
EFTA_R1_01730427
EFTA02565758
6.509
9.838
Principal Window @ Base Case
Mar13 to Oct37
Spread over Tsy
136
575
912
Writedown %
14.66%
Duration
3.18
2.97
2.71
Current Credit Enhancement:
2.38%
WAL
4.05
4.03
3.84
60+ Delinquencies
7.08
Principal Window
Mar13 to Mar36
Mar13 to Oct37
Mar13 to Oct37
4
EFTA_R1_01730428
EFTA02565759
60+ Delinquency Coverage
0.34x
Principal Writedown
29.22%
14.66%
3.28%
Total Collat Loss
0.54%
0.46%
0.39%
UNDERLYING COLLATERAL DESCRIPTION
Total Liquidation
7.59%
6.83%
5.55%
Average Loan Balance ($,000s)
296
Loan Count
145
HISTORICAL PERFORMANCE
Mortgage Type
Seasoned Prime 3Oyr Fix
5
EFTA_R1_01730429
EFTA02565760
1 MOS
3 MOS
6 MOS
Wtd Avg Mortgage Coupon
5.655%
CPR
27.23
31.87
27.45
Wtd Avg FICO Score
735
CDR
0.00
4.64
2.20
Wtd Avg Orig Loan•to•Value
54.81%
SEV
NA
30.01
30.01
HPI Adj LTV
56.15%
Weighted Avg Loan Age
105
6
EFTA_R1_01730430
EFTA02565761
Owner Occupied
96.17
Top 1 Geo Concentration
CA 49%
Top 2 Geo Concentration
TX 7%
Top 3 Geo Concentration
NY 5%
Always Current (24 mos)
86.81%
IMPORTANT DISCLAIMER:
Non-agency RM8S is a complex fixed income product and is not suitable for all investors. Please note that while desk
assumptions are driven by a number of collateral and macro factors, the historical performance of a deal is not
indicative of its future performance. Additionally, this message is a product of sales and trading and is not a research
report. Other key risks to consider are outlined below:
All investments are subject to possible loss of principal
Non-Agency bonds may have limited liquidity and clients should be aware that the secondary market for
mortgage-backed securities has experienced periods of illiquidity and may do so in the future. Illiquidity means that
there may not be any purchasers for your class of certificates. Although any class of certificates may experience
illiquidity, it is more likely that classes that are lower in the capital structure and non-investment grade related may
experience greater illiquidity than more senior, investment-grade rated classes.
High Yield Non-Agency bonds are speculative non-investment grade bonds that have higher risk of default or
other adverse credit events which are appropriate for high risk investors only
7
EFTA_R1_01730431
EFTA02565762
Non-Agency bonds are intended for clients with a minimum total net worth of $50mm. Please make sure your client
fulfills this requirement before soliciting this order.
This commentary is a product of JPMorgan Global Wealth Managements Taxable Fixed Income Trading Desk and not
JPMorgan's Research Department. The views expressed in this trading desk commentary may differ from those of
JPMorgan's Research Department. Any opinions expressed in this trading desk commentary are subject to change
without notice and JPMorgan is under no obligation to update or keep this information current.
Bee-Ann Benson I Vice President I J.P. Morgan Global Wealth Management
270 Park Avenue, Floor 5, New York, New York 10017
T: 212 464 0608 I F: 212 464 1129 I
This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale
of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity
disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
8
EFTA_R1_01730432
EFTA02565763
Technical Artifacts (13)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
212 464 0608Phone
212 464 1129Phone
2565756Phone
2565757Phone
2565758Phone
2565759Phone
2565760Phone
2565761Phone
2565762Phone
2565763URL
http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage.htmlURL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.